charts: 7447
Data license: CC-BY
This data as json
id | slug | type | config | createdAt | updatedAt | lastEditedAt | publishedAt | lastEditedByUserId | publishedByUserId | isIndexable | title | subtitle | note | title_plus_variant | configWithDefaults |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7447 | statin-use-for-prevention-of-cardiovascular-disease | LineChart | { "id": 7447, "note": "Eligibility for statin therapy for primary prevention is for those without cardiovascular disease but with either diagnosed diabetes or a 10-year cardiovascular risk above 20% as per the 2019 WHO guidelines. For secondary prevention, it applies to individuals with a history of cardiovascular disease.", "slug": "statin-use-for-prevention-of-cardiovascular-disease", "title": "Statin use for prevention of cardiovascular disease", "yAxis": { "facetDomain": "shared" }, "$schema": "https://files.ourworldindata.org/schemas/grapher-schema.004.json", "version": 1, "subtitle": "Share of eligible individuals who report using [statins](#dod:statins) for prevention of [cardiovascular disease](#dod:cvd).", "originUrl": "OurWorldInData.org/cardiovascular-diseases", "colorScale": { "baseColorScheme": "OwidCategoricalB" }, "dimensions": [ { "display": { "name": "Secondary prevention", "includeInTable": true }, "property": "y", "variableId": 815286 }, { "display": { "name": "Primary prevention", "unit": "%", "shortUnit": "%", "includeInTable": true, "numDecimalPlaces": 1 }, "property": "y", "variableId": 815287 } ], "selectedEntityNames": [ "Iran", "Sri Lanka", "Lebanon", "Kenya", "Uganda", "Myanmar", "Belarus" ], "selectedFacetStrategy": "metric" } |
2023-12-05 17:07:22 | 2024-04-08 12:13:54 | 2023-12-05 17:07:22 | 72 | 0 | Statin use for prevention of cardiovascular disease | Share of eligible individuals who report using [statins](#dod:statins) for prevention of [cardiovascular disease](#dod:cvd). | Eligibility for statin therapy for primary prevention is for those without cardiovascular disease but with either diagnosed diabetes or a 10-year cardiovascular risk above 20% as per the 2019 WHO guidelines. For secondary prevention, it applies to individuals with a history of cardiovascular disease. | Statin use for prevention of cardiovascular disease () | { "$schema": "https://files.ourworldindata.org/schemas/grapher-schema.004.json", "map": { "projection": "World", "hideTimeline": false, "colorScale": { "baseColorScheme": "default", "equalSizeBins": true, "binningStrategy": "ckmeans", "customNumericColorsActive": false, "colorSchemeInvert": false, "binningStrategyBinCount": 5 }, "timeTolerance": 0, "toleranceStrategy": "closest", "tooltipUseCustomLabels": false, "time": "latest" }, "maxTime": "latest", "baseColorScheme": "default", "yAxis": { "removePointsOutsideDomain": false, "scaleType": "linear", "canChangeScaleType": false, "facetDomain": "shared" }, "tab": "chart", "matchingEntitiesOnly": false, "hasChartTab": true, "hideLegend": false, "hideLogo": false, "hideTimeline": false, "colorScale": { "baseColorScheme": "default", "equalSizeBins": true, "binningStrategy": "ckmeans", "customNumericColorsActive": false, "colorSchemeInvert": false, "binningStrategyBinCount": 5 }, "scatterPointLabelStrategy": "year", "selectedFacetStrategy": "metric", "isPublished": false, "invertColorScheme": false, "version": 1, "logo": "owid", "entityType": "country or region", "facettingLabelByYVariables": "metric", "addCountryMode": "add-country", "compareEndPointsOnly": false, "type": "LineChart", "hasMapTab": false, "stackMode": "absolute", "minTime": "earliest", "hideAnnotationFieldsInTitle": { "entity": false, "time": false, "changeInPrefix": false }, "xAxis": { "removePointsOutsideDomain": false, "scaleType": "linear", "canChangeScaleType": false, "facetDomain": "shared" }, "hideConnectedScatterLines": false, "showNoDataArea": true, "zoomToSelection": false, "showYearLabels": false, "hideLinesOutsideTolerance": false, "hideTotalValueLabel": false, "hideScatterLabels": false, "sortBy": "total", "sortOrder": "desc", "hideFacetControl": true, "entityTypePlural": "countries", "missingDataStrategy": "auto", "id": 7447, "note": "Eligibility for statin therapy for primary prevention is for those without cardiovascular disease but with either diagnosed diabetes or a 10-year cardiovascular risk above 20% as per the 2019 WHO guidelines. For secondary prevention, it applies to individuals with a history of cardiovascular disease.", "slug": "statin-use-for-prevention-of-cardiovascular-disease", "title": "Statin use for prevention of cardiovascular disease", "subtitle": "Share of eligible individuals who report using [statins](#dod:statins) for prevention of [cardiovascular disease](#dod:cvd).", "originUrl": "OurWorldInData.org/cardiovascular-diseases", "dimensions": [ { "display": { "name": "Secondary prevention", "includeInTable": true }, "property": "y", "variableId": 815286 }, { "display": { "name": "Primary prevention", "unit": "%", "shortUnit": "%", "includeInTable": true, "numDecimalPlaces": 1 }, "property": "y", "variableId": 815287 } ], "selectedEntityNames": [ "Iran", "Sri Lanka", "Lebanon", "Kenya", "Uganda", "Myanmar", "Belarus" ] } |